跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,721 条关于
“POINT-GUARD”
全部
7,721
临床试验
4,774
药物
33
机构
50
资讯
2,864
去年
Transverse Medical Secures Over $10M in Series B2 Funding to Advance Stroke Prevention Technology
2年前
GUARD-AF Trial: iRhythm's Zio XT Patch Increases AF Detection in Primary Care
2年前
First Patient Dosed in Guard Therapeutics' Phase 2b Study POINTER
去年
Philikos Initiates Phase 1/2 Trial of T-Guard for Diffuse Cutaneous Systemic Sclerosis
去年
Guard Therapeutics' POINTER Study Reaches 25% Enrollment Milestone
2年前
Guard Therapeutics' RMC-035 Shows Kidney-Protective Effect in Phase 2 Trial
11个月前
Guard Therapeutics' RMC-035 Fails Phase 2b POINTER Trial Despite Earlier Positive Results
去年
Guard Therapeutics Announces SEK 150M Rights Issue to Advance Kidney Protection Drug Development
去年
Boston Scientific Resumes Enrollment in AVANT GUARD Atrial Fibrillation Trial
2年前
Nerandomilast Shows Promise in Phase 3 Trial for Idiopathic Pulmonary Fibrosis
第 1 页,共 287 页
上一页
下一页